Professor Yeoung Jee Cho
Professor

Yeoung Jee Cho

Email: 

Background

Professor Yeoungjee Cho is a consultant nephrologist from Princess Alexandra Hospital in Brisbane, Australia. She is a current Deputy Co-Chair of executive operations secretariat of the Australasian Kidney Trials Network. She is an elected member of Council for International Society for Peritoneal Dialysis, and is Chair of ISPD International Studies Committee. She has published >190 manuscripts in the field of peritoneal dialysis in peer-reviewed journals. She is a member of the steering committee for the Standardised Outcomes in Nephrology – Peritoneal Dialysis (SONG-PD) and a deputy editor-in-chief of Peritoneal Dialysis International. She is a current recipient of the Australian National Health and Medical Research Council Emerging Leadership Investigator Grant.

Availability

Professor Yeoung Jee Cho is:
Available for supervision

Search Professor Yeoung Jee Cho’s works on UQ eSpace

242 works between 2009 and 2026
All (242) Journal Article (205) Other Outputs (2) Conference Publication (30) Book Chapter (5)

201 - 220 of 242 works

2016

Book Chapter

Aminoglycoside use in patients with chronic kidney disease

Nataatmadja, Melissa, Cho, Yeoungjee, Lloyd, Jess and Johnson, David W. (2016). Aminoglycoside use in patients with chronic kidney disease. Aminoglycosides: pharmacology, clinical uses and health effects. (pp. 53-76) edited by Ruthie Alves. New York, NY, United States: Nova Science Publishers.

Aminoglycoside use in patients with chronic kidney disease

2016

Journal Article

Higher dialysate matrix metalloproteinase-2 levels are associated with peritoneal membrane dysfunction

Cho, Yeoungjee, Johnson, David W., Vesey, David A., Hawley, Carmel M., Pascoe, Elaine M., Clarke, Margaret and Topley, Nicholas (2016). Higher dialysate matrix metalloproteinase-2 levels are associated with peritoneal membrane dysfunction. Peritoneal Dialysis International, 36 (1), 16-25. doi: 10.3747/pdi.2013.00274

Higher dialysate matrix metalloproteinase-2 levels are associated with peritoneal membrane dysfunction

2015

Journal Article

Neutrophil–lymphocyte ratio predicts cardiovascular and all-cause mortality in hemodialysis patients

Neuen, Brendon L., Leather, Nicole, Greenwood, Alice M., Gunnarsson, Ronny, Cho, Yeoungjee and Mantha, Murty L. (2015). Neutrophil–lymphocyte ratio predicts cardiovascular and all-cause mortality in hemodialysis patients. Renal Failure, 38 (1), 70-76. doi: 10.3109/0886022X.2015.1104990

Neutrophil–lymphocyte ratio predicts cardiovascular and all-cause mortality in hemodialysis patients

2015

Journal Article

Prevention of peritoneal dialysis-related infections

Campbell, Denise J., Johnson, David W., Mudge, David W., Gallagher, Martin P. and Craig, Jonathan C. (2015). Prevention of peritoneal dialysis-related infections. Nephrology Dialysis Transplantation, 30 (9), 1461-1472. doi: 10.1093/ndt/gfu313

Prevention of peritoneal dialysis-related infections

2015

Other Outputs

Inflammation in peritoneal dialysis: investigating the roles of biocompatible solutions and biological markers

Cho, Yeoungjee (2015). Inflammation in peritoneal dialysis: investigating the roles of biocompatible solutions and biological markers. PhD Thesis, School of Medicine, The University of Queensland. doi: 10.14264/uql.2015.860

Inflammation in peritoneal dialysis: investigating the roles of biocompatible solutions and biological markers

2015

Journal Article

The role of monitoring vancomycin levels in patients with peritoneal dialysis-associated peritonitis

Stevenson, Sarah, Tang, Wen, Cho, Yeoungjee, Mudge, David W., Hawley, Carmel M., Badve, Sunil V. and Johnson, David W. (2015). The role of monitoring vancomycin levels in patients with peritoneal dialysis-associated peritonitis. Peritoneal Dialysis International, 35 (2), 222-228. doi: 10.3747/pdi.2013.00156

The role of monitoring vancomycin levels in patients with peritoneal dialysis-associated peritonitis

2015

Journal Article

Utility of urinary biomarkers in predicting loss of residual renal function: the balANZ trial

Cho, Yeoungjee, Johnson, David W., Vesey, David A., Hawley, Carmel M., Clarke, Margaret and Topley, Nicholas (2015). Utility of urinary biomarkers in predicting loss of residual renal function: the balANZ trial. Peritoneal Dialysis International, 35 (2), 159-171. doi: 10.3747/pdi.2013.00170

Utility of urinary biomarkers in predicting loss of residual renal function: the balANZ trial

2015

Journal Article

Honey in the prevention and treatment of infection in the CKD population: a narrative review

Francis, Anna, Cho, Yeoungjee and Johnson, David W. (2015). Honey in the prevention and treatment of infection in the CKD population: a narrative review. Evidence-based Complementary and Alternative Medicine, 2015 (1) 261425, 1-8. doi: 10.1155/2015/261425

Honey in the prevention and treatment of infection in the CKD population: a narrative review

2015

Conference Publication

Outcomes of Integrated Home Dialysis Care: a Multi-Centre Registry Study

Nadeau-Fredette, Annie-Claire, Chan, Christopher T., Cho, Yeoungjee, Hawley, Carmel, Pascoe, Elaine, Clayton, Philip A., Leblanc, Martine, Boudville, Neil, Polkinghorne, Kevan R. and Johnson, David W. (2015). Outcomes of Integrated Home Dialysis Care: a Multi-Centre Registry Study. 52nd Congress of the European Renal Association European Dialysis and Transplant Assocation, London, United Kingdom, 28-31 May 2015. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/ndt/gfv180.10

Outcomes of Integrated Home Dialysis Care: a Multi-Centre Registry Study

2015

Journal Article

Baseline Serum Interleukin-6 Predicts Cardiovascular Events in Incident Peritoneal Dialysis Patients

Cho, Yeoungjee, Johnson, David W., Vesey, David A., Hawley, Carmel M., Pascoe, Elaine M., Clarke, Margaret and Topley, Nicholas (2015). Baseline Serum Interleukin-6 Predicts Cardiovascular Events in Incident Peritoneal Dialysis Patients. Peritoneal Dialysis International, 35 (1), 35-42. doi: 10.3747/pdi.2013.00272

Baseline Serum Interleukin-6 Predicts Cardiovascular Events in Incident Peritoneal Dialysis Patients

2015

Journal Article

Outcomes of integrated home dialysis care: a multi-centre, multi-national registry study

Nadeau-Fredette, Annie-Claire, Chan, Christopher T., Cho, Yeoungjee, Hawley, Carmel M., Pascoe, Elaine M., Clayton, Philip A., Polkinghorne, Kevan R., Boudville, Neil, Leblanc, Martine and Johnson, David W. (2015). Outcomes of integrated home dialysis care: a multi-centre, multi-national registry study. Nephrology Dialysis Transplantation, 30 (11), 1897-1904. doi: 10.1093/ndt/gfv132

Outcomes of integrated home dialysis care: a multi-centre, multi-national registry study

2014

Journal Article

Peritoneal dialysis outcomes after temporary haemodialysis transfer for peritonitis

Cho, Yeoungjee, Badve, Sunil V., Hawley, Carmel M., McDonald, Stephen P., Brown, Fiona G., Boudville, Neil, Clayton, Philip and Johnson, David W. (2014). Peritoneal dialysis outcomes after temporary haemodialysis transfer for peritonitis. Nephrology, Dialysis, Transplantation, 29 (10), 1940-1947. doi: 10.1093/ndt/gfu050

Peritoneal dialysis outcomes after temporary haemodialysis transfer for peritonitis

2014

Journal Article

Economic Evaluation of Neutral-pH, Low-Glucose Degradation Product Peritoneal Dialysis Solutions Compared With Standard Solutions: A Secondary Analysis of the balANZ Trial

Howard K., Hayes A., Cho Y., Cass A., Clarke M. and Johnson D.W. (2014). Economic Evaluation of Neutral-pH, Low-Glucose Degradation Product Peritoneal Dialysis Solutions Compared With Standard Solutions: A Secondary Analysis of the balANZ Trial. American Journal of Kidney Diseases, 65 (5), 773-779. doi: 10.1053/j.ajkd.2014.12.017

Economic Evaluation of Neutral-pH, Low-Glucose Degradation Product Peritoneal Dialysis Solutions Compared With Standard Solutions: A Secondary Analysis of the balANZ Trial

2014

Journal Article

Does the use of neutral pH, low glucose degradation product peritoneal dialysis fluids lead to better patient outcomes?

Cho, Yeoungjee and Johnson, David W. (2014). Does the use of neutral pH, low glucose degradation product peritoneal dialysis fluids lead to better patient outcomes?. Current Opinion in Nephrology and Hypertension, 23 (2), 192-197. doi: 10.1097/01.mnh.0000441046.13912.1f

Does the use of neutral pH, low glucose degradation product peritoneal dialysis fluids lead to better patient outcomes?

2014

Journal Article

The role of monitoring gentamicin levels in patients with gram-negative peritoneal dialysis-associated peritonitis

Tang, Wen, Cho, Yeoungjee, Hawley, Carmel M., Badve, Sunil V. and Johnson, David W. (2014). The role of monitoring gentamicin levels in patients with gram-negative peritoneal dialysis-associated peritonitis. Peritoneal Dialysis International, 34 (2), 219-226. doi: 10.3747/pdi.2012.00318

The role of monitoring gentamicin levels in patients with gram-negative peritoneal dialysis-associated peritonitis

2014

Journal Article

Biocompatible dialysis fluids for peritoneal dialysis

Cho, Yeoungjee, Johnson, David W., Craig, Jonathan C., Strippoli, Giovanni F.M., Badve, Sunil V. and Wiggins, Kathryn J. (2014). Biocompatible dialysis fluids for peritoneal dialysis. Cochrane Database of Systematic Reviews, 2014 (3) CD007554. doi: 10.1002/14651858.CD007554.pub2

Biocompatible dialysis fluids for peritoneal dialysis

2014

Journal Article

Dialysate interleukin-6 predicts increasing peritoneal solute transport rate in incident peritoneal dialysis patients

Cho, Yeoungjee, Johnson, David W., Vesey, David A., Hawley, Carmel M., Pascoe, Elaine M., Clarke, Margaret, Topley, Nicholas and on behalf of the balANZ Trial Investigators (2014). Dialysate interleukin-6 predicts increasing peritoneal solute transport rate in incident peritoneal dialysis patients. BMC Nephrology, 15 (1) 8. doi: 10.1186/1471-2369-15-8

Dialysate interleukin-6 predicts increasing peritoneal solute transport rate in incident peritoneal dialysis patients

2014

Journal Article

Outcomes of nephrologist-inserted peritoneal catheters in indigenous patients from far north Queensland

Cho, Yeoungjee, Baer, Richard, Killen, John P. and Mantha, Murty (2014). Outcomes of nephrologist-inserted peritoneal catheters in indigenous patients from far north Queensland. Peritoneal Dialysis International, 34 (6), 663-667. doi: 10.3747/pdi.2011.00261

Outcomes of nephrologist-inserted peritoneal catheters in indigenous patients from far north Queensland

2014

Journal Article

Peritoneal dialysis-related peritonitis: Towards improving evidence, practices, and outcomes

Cho, Yeoungjee and Johnson, David W. (2014). Peritoneal dialysis-related peritonitis: Towards improving evidence, practices, and outcomes. American Journal of Kidney Diseases, 64 (2), 278-289. doi: 10.1053/j.ajkd.2014.02.025

Peritoneal dialysis-related peritonitis: Towards improving evidence, practices, and outcomes

2014

Journal Article

Clinical causes of inflammation in peritoneal dialysis patients

Cho, Yeoungjee, Hawley, Carmel M. and Johnson, David W. (2014). Clinical causes of inflammation in peritoneal dialysis patients. International Journal of Nephrology, 2014 909373, 909373-9. doi: 10.1155/2014/909373

Clinical causes of inflammation in peritoneal dialysis patients

Current funding

  • 2026 - 2031
    STEP-PD: STarting incrEmental Prescription of PD
    NHMRC MRFF CTA - Clinical Trials Activity
    Open grant
  • 2026 - 2029
    STEP-PD: Starting incremental Prescription of Peritoneal Dialysis
    Investigator-initiated research: chronic renal therapies
    Open grant
  • 2022 - 2027
    Improving outcomes in peritoneal dialysis through patient-centred clinical trials
    NHMRC Investigator Grants
    Open grant

Past funding

  • 2021 - 2023
    Patient perspectives and involvement in co-design of a trial evaluating interventions to improve gut health in peritoneal dialysis - GUT PD Study (ISPD grant led by Eastern Institute of Technology)
    Eastern Institute of Technology
    Open grant
  • 2018 - 2020
    The TEACH-PD study: a Targeted Education ApproaCH to improve Peritoneal Dialysis outcomes
    Metro South Hospital and Health Service
    Open grant
  • 2018 - 2022
    Targeted Education Approach to Improve Peritoneal Dialysis Outcomes (TEACH-PD) - A Cluster RCT
    Baxter Healthcare Pty Ltd
    Open grant
  • 2016
    The TECH-PD trial (pilot study)
    International Society of Peritoneal Dialysis
    Open grant
  • 2012 - 2013
    The utility of matrix metalloproteinase-2 (MMP-2) to predict peritoneal injury in the incident PD population
    Kidney Health Australia
    Open grant

Availability

Professor Yeoung Jee Cho is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    Patient-centred strategies to improve life goal attainment in people with kidney disease

    Principal Advisor

    Other advisors: Professor David Johnson

  • Doctor Philosophy

    Predictors of and interventions to improve uptake and technique survival and reduce burden of home dialysis treatment

    Associate Advisor

    Other advisors: Professor David Johnson

  • Doctor Philosophy

    Novel Approaches to Cardiovascular Risk Stratification in Chronic Kidney Disease

    Associate Advisor

    Other advisors: Professor David Johnson

Completed supervision

Enquiries

For media enquiries about Professor Yeoung Jee Cho's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au